New Market Research Report: GlaxoSmithKline plc: PharmaVitae Profile

New Pharmaceuticals research report from Datamonitor is now available from Fast Market Research
Spread the Word
Listed Under

• Glaxosmithkline


Massachusetts - US

May 17, 2011 - PRLog -- Introduction

This analysis examines the historical and forecast performance for GlaxoSmithKline in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
Features and benefits

* Gain insight into GlaxoSmithKline's strategic outlook across the next 6 years.* Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source.


Strategic insight into the prospects for GlaxoSmithKline over the next six years. Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales.
Your key questions answered

* Benchmark GlaxoSmithKline's performance against key rivals in the prescription pharmaceutical sector* Assess GlaxoSmithKline's continued diversification strategy with vaccines and emerging markets positioned as key growth opportunities.* Analyse how life-cycle managment (and a lack of generic competition) will facilitate GSK's continued strong position in the global asthma/COPD market.

Full Report Details at

Partial Table of Contents:

About the PharmaVitae team
Chapter 1 About this profile
PharmaVitae Explorer database
Chapter structure
Data sourcing
Chapter 2 Executive summary
Key findings
Prescription pharmaceutical sales and growth rate performance, 2003-15
Financial performance, 2003-15
GlaxoSmithKline: PharmaVitae forecasts at a glance
Strategic insight
SWOT analysis
Chapter 3 Quarterly news update
Latest quarterly sales
Latest quarterly financial analysis
Latest comment
Latest prescription pharma product news
Latest corporate news
Future product milestones
Chapter 4 Company introduction
Key findings
M&A history
Chapter 5 Company sales
Key findings
Prescription pharmaceutical sales and growth rate analysis, 2003-15
Product analysis
Therapy area analysis
Geographic analysis
Launch/core/expiry analysis
Molecule type analysis
Externalization analysis
Chapter 6 Company financials
Key findings
Reconciliation between PharmaVitae-formatted prescription pharma sales and company-reported total sales, 2003-09
Operating costs and profit analysis
Chapter 7 Key products
Chapter 8 Appendix
Exchange rates
About Datamonitor
Datamonitor consulting

Table 1: GlaxoSmithKline - PharmaVitae forecasts at a glance
Table 2: GlaxoSmithKline quarterly sales ($m), Q309-Q310
Table 3: GlaxoSmithKline quarterly financials ($m), Q309-Q310
Table 4: GlaxoSmithKline future product milestones, 2010-12
Table 5: GlaxoSmithKline product portfolio overview ($m), 2003-09
Table 6: GlaxoSmithKline product portfolio overview ($m), 2009-15
Table 7: GlaxoSmithKline prescription pharmaceutical sales by therapy area ($m), 2009-15
Table 8: GlaxoSmithKline prescription pharmaceutical sales by geographic region ($m), 2009-15
Table 9: GlaxoSmithKline launch portfolio overview ($m), 2009-15
Table 10: GlaxoSmithKline core portfolio overview ($m), 2009-15
Table 11: GlaxoSmithKline expiry portfolio overview ($m), 2009-15
Table 12: GlaxoSmithKline prescription pharmaceutical sales by molecule type ($m), 2009-15
Table 13: GlaxoSmithKline vaccine sales ($m), 2008-14
Table 14: GlaxoSmithKline prescription pharmaceutical sales by source ($m), 2009-15
Table 15: Total GlaxoSmithKline sales by business unit ($m), 2003-09
Table 16: GlaxoSmithKline operating revenue/cost analysis ($m), 2003-09
Table 17: GlaxoSmithKline operating cost ratio analysis (% of total revenues), 2003-09
Table 18: GlaxoSmithKline operating cost ratio analysis (% of total revenues), 2009-15
Table 19: GlaxoSmithKline operating revenue/cost analysis ($m), 2009-15
Table 20: GlaxoSmithKline Key products overview
Table 21: Beyond Advair: overview
Table 22: Beyond Advair: sales forecast ($m), 2009-15
Table 23: Duodart: overview
Table 24: Duodart: sales forecast ($m), 2009-15
Table 25: Almorexant: overview
Table 26: Almorexant: sales forecast ($m), 2009-15
Table 27: Tykerb/Tyverb: overview
Table 28: Tykerb/Tyverb: sales forecast ($m), 2009-15
Table 29: Synflorix: overview
Table 30: Synflorix: sales forecast ($m), 2009-15
Table 31: Valtrex: overview
Table 32: Valtrex: sales forecast ($m), 2009-15
Table 33: Seretide/Advair: overview
Table 34: Seretide/Advair: sales forecast ($m), 2009-15
Table 35: Influenza Vaccines: overview
Table 36: Influenza Vaccines: sales forecast ($m), 2009-15
Table 37: Flixotide/Flovent: overview
Table 38: Flixotide/Flovent: sales forecast ($m), 2009-15
Table 39: Avandia: overview
Table 40: Avandia: sales forecast ($m), 2009-15
Table 41: Exchange rates, 2010

Figure 1: The PharmaVitae Explorer
Figure 2: GlaxoSmithKline prescription pharmaceutical performance, sales ($m) and growth rate (%), 2003-15
Figure 3: GlaxoSmithKline's financial performance ($m), 2003-15
Figure 4: GlaxoSmithKline launch/core/expiry configuration ($m), 2002-08
Figure 5: GlaxoSmithKline launch/core/expiry configuration ($m), 2009-15
Figure 6: GlaxoSmithKline SWOT analysis
Figure 7: M&A/divestment history

Full Table of Contents is available at:

About Datamonitor

The Datamonitor Group is a world-leading provider of premium global business information, delivering independent data, analysis and opinion across the Automotive, Consumer Markets, Energy & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and Telecoms industries. Datamonitor's market intelligence products and services ensure that you will achieve your desired commercial goals by giving you the insight you need to best respond to your competitive environment.  View more research from Datamonitor at

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
Email:*** Email Verified
Industry:Medical, Research, Biotech
Location:Massachusetts - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Fast Market Research PRs
Trending News
Top Daily News
Top Weekly News

Like PRLog?
Click to Share